Comment on “Validation and Modeling of Flow Cytometric CD36 Coefficient of Variation (CV) Analysis in the Diagnosis of Lower- Risk Myelodysplastic Syndromes”

Daungsupawong, Hinpetch; Wiwanitkit, Viroj

Comment on “Validation and Modeling of Flow Cytometric CD36 Coefficient of Variation (CV) Analysis in the Diagnosis of Lower- Risk Myelodysplastic Syndromes” [Turk J Hematol]

Turk J Hematol. 2026; 43(1): 80-81 | DOI: 10.4274/tjh.galenos.2025.79735

Comment on “Validation and Modeling of Flow Cytometric CD36 Coefficient of Variation (CV) Analysis in the Diagnosis of Lower- Risk Myelodysplastic Syndromes”

Hinpetch Daungsupawong¹, Viroj Wiwanitkit²
¹Private Academic Consultant, Phonhong, Lao People’s Democratic Republic
²Saveetha Dental College, Chennai, India

Keywords: Flow cytometry, CD36, Coefficient of variation, Myelodysplastic syndromes

“Alt Risk Miyelodisplastik Sendromların Tanısında Akım Sitometrisi CD36 Varyasyon Katsayısı (CV) Analizinin Validasyonu ve Modellemesi” Üzerine Yorum

Hinpetch Daungsupawong¹, Viroj Wiwanitkit²
¹Private Academic Consultant, Phonhong, Lao People’s Democratic Republic
²Saveetha Dental College, Chennai, India

Anahtar Kelimeler: Akım sitometrisi, CD36, Varyasyon katsayısı, Miyelodisplastik sendromlar

Corresponding Author: Hinpetch Daungsupawong, Thailand
Manuscript Language: English

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar